Abeona Therapeutics (ABEO) Reports In-Line Q1 EPS

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.54), in-line with the analyst estimate of ($0.54).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat